Published in Proteomics on December 01, 2008
Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study. Mol Cell Proteomics (2013) 1.09
Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene (2012) 1.08
Network-based pipeline for analyzing MS data: an application toward liver cancer. J Proteome Res (2011) 1.07
Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression. Cell Death Dis (2015) 0.81
Far Upstream Element Binding Protein Plays a Crucial Role in Embryonic Development, Hematopoiesis, and Stabilizing Myc Expression Levels. Am J Pathol (2016) 0.80
BRCA1 modulates the expression of hnRNPA2B1 and KHSRP. Cell Cycle (2010) 0.80
KSRP/FUBP2 Is a Binding Protein of GO-Y086, a Cytotoxic Curcumin Analogue. ACS Med Chem Lett (2010) 0.79
Histidine decarboxylase is identified as a potential biomarker of intestinal mucosal injury in patients with acute intestinal obstruction. Mol Med (2011) 0.76
Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma. Int J Oncol (2016) 0.76
Capturing and identification of differentially expressed fucome by a gel free and label free approach. J Chromatogr B Analyt Technol Biomed Life Sci (2015) 0.75
Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma. PLoS One (2017) 0.75
Diverse roles of the nucleic acid-binding protein KHSRP in cell differentiation and disease. Wiley Interdiscip Rev RNA (2015) 0.75
Bathing in carbon dioxide-enriched water alters protein expression in keratinocytes of skin tissue in rats. Int J Biometeorol (2016) 0.75
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med (2003) 5.97
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med (2003) 4.12
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology (2006) 3.80
Guidelines for the next 10 years of proteomics. Proteomics (2006) 3.61
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med (2005) 3.46
Serum autoantibodies as biomarkers for early cancer detection. FEBS J (2009) 1.94
Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev (2007) 1.90
Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics (2007) 1.80
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus. Liver Int (2011) 1.75
Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology (2009) 1.70
iTRAQ based quantitative proteomics approach validated the role of calcyclin binding protein (CacyBP) in promoting colorectal cancer metastasis. Mol Cell Proteomics (2013) 1.61
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. Gastrointest Endosc (2012) 1.55
A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J Virol (2004) 1.53
"Proteomineering" or not? The debate on biomarker discovery in sera continues. J Proteomics (2011) 1.50
Proteomic analysis of shrimp white spot syndrome viral proteins and characterization of a novel envelope protein VP466. Mol Cell Proteomics (2002) 1.49
Dynamic secretion changes in the salt glands of the mangrove tree species Avicennia officinalis in response to a changing saline environment. Plant Cell Environ (2013) 1.49
PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Cancer Cell (2010) 1.48
Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion. Gut (2012) 1.47
Membrane proteins and membrane proteomics. Proteomics (2008) 1.40
Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics (2006) 1.39
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J Hepatol (2010) 1.38
Prediction of RNA-binding proteins from primary sequence by a support vector machine approach. RNA (2004) 1.36
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol (2010) 1.35
Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol (2004) 1.34
A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection. Hepatology (2004) 1.34
ERCP in patients with periampullary diverticulum. Hepatogastroenterology (2003) 1.34
Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication. J Virol (2004) 1.32
Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int (2006) 1.30
Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway. J Virol (2004) 1.24
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol (2008) 1.21
The severe acute respiratory syndrome coronavirus 3a is a novel structural protein. Biochem Biophys Res Commun (2005) 1.21
The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol (2007) 1.16
Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol (2013) 1.15
Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells. Mol Cell Proteomics (2008) 1.14
Effect of training datasets on support vector machine prediction of protein-protein interactions. Proteomics (2005) 1.11
A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers. Proteomics (2004) 1.11
Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria. J Med Virol (2008) 1.10
Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology (2002) 1.10
Practical difficulties in the management of hepatitis B in the Asia-Pacific region. J Gastroenterol Hepatol (2004) 1.09
Network-based pipeline for analyzing MS data: an application toward liver cancer. J Proteome Res (2011) 1.07
A comparative proteomic analysis reveals a new bi-lobe protein required for bi-lobe duplication and cell division in Trypanosoma brucei. PLoS One (2010) 1.07
Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics (2005) 1.05
The economics of treating chronic hepatitis B in Asia. Hepatol Int (2008) 1.04
Shotgun identification of the structural proteome of shrimp white spot syndrome virus and iTRAQ differentiation of envelope and nucleocapsid subproteomes. Mol Cell Proteomics (2007) 1.04
Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions. Hepatol Int (2010) 1.03
Characterization of viral proteins encoded by the SARS-coronavirus genome. Antiviral Res (2005) 1.01
Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines. J Proteome Res (2011) 1.01
Cancer proteomics. Mass Spectrom Rev (2012) 1.00
Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model. Proteomics (2008) 0.99
Subcellular fractionation methods and strategies for proteomics. Proteomics (2010) 0.97
Rac1 GTPase is activated by hepatitis B virus replication--involvement of HBX. Biochim Biophys Acta (2007) 0.97
Characterization of a novel envelope protein (VP281) of shrimp white spot syndrome virus by mass spectrometry. J Gen Virol (2002) 0.96
Characterization of a unique group-specific protein (U122) of the severe acute respiratory syndrome coronavirus. J Virol (2004) 0.96
Over-expression of severe acute respiratory syndrome coronavirus 3b protein induces both apoptosis and necrosis in Vero E6 cells. Virus Res (2006) 0.95
Structure and evolutionary origin of Ca(2+)-dependent herring type II antifreeze protein. PLoS One (2007) 0.95
Prevalence and clinical associations of posttransplant fatty liver disease. Liver Int (2007) 0.95
Role of root hydrophobic barriers in salt exclusion of a mangrove plant Avicennia officinalis. Plant Cell Environ (2014) 0.94
Proteomic analysis of colorectal cancer metastasis: stathmin-1 revealed as a player in cancer cell migration and prognostic marker. J Proteome Res (2012) 0.94
Proteomic analysis of plasma membrane and tonoplast from the leaves of mangrove plant Avicennia officinalis. Proteomics (2014) 0.94
Molecular and functional characterization of drug-metabolizing enzymes and transporter expression in the novel spontaneously immortalized human hepatocyte line HC-04. Toxicol In Vitro (2007) 0.94
Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/-) mice: two-stage oxidative injury. Toxicol Appl Pharmacol (2008) 0.94
Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. J Proteome Res (2012) 0.93
Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein. Biochem Biophys Res Commun (2004) 0.93
Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Clin Pharmacokinet (2006) 0.93
Severe acute respiratory syndrome coronavirus protein 7a interacts with hSGT. Biochem Biophys Res Commun (2006) 0.92
A quantitative chemical proteomics approach to profile the specific cellular targets of andrographolide, a promising anticancer agent that suppresses tumor metastasis. Mol Cell Proteomics (2014) 0.92
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection. J Clin Invest (2013) 0.91
CD81 engineered with endocytotic signals mediates HCV cell entry: implications for receptor usage by HCV in vivo. Virology (2003) 0.91
Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein. J Proteome Res (2013) 0.90
Proteomic analysis of protein profiles during early development of the zebrafish, Danio rerio. Proteomics (2006) 0.90
Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human fetal liver cells: role of mitochondrial permeability transition. Free Radic Biol Med (2005) 0.90
Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis. Liver Transpl (2006) 0.90
Public misperceptions about transmission of hepatitis B virus in Singapore. Ann Acad Med Singapore (2007) 0.89
Upregulation of plasma C9 protein in gastric cancer patients. Proteomics (2010) 0.89
Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity. Biochem J (2004) 0.89
Differential recovery of membrane proteins after extraction by aqueous methanol and trifluoroethanol. Proteomics (2007) 0.89
Histone H4 histidine kinase displays the expression pattern of a liver oncodevelopmental marker. Carcinogenesis (2004) 0.89
Proteomic studies of the Singapore grouper iridovirus. Mol Cell Proteomics (2005) 0.89
Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc. J Gastroenterol Hepatol (2002) 0.89
Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int J Cancer (2002) 0.88
Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus. Antiviral Res (2006) 0.88
Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma. Int J Oncol (2007) 0.88
Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse. J Proteomics (2013) 0.87
Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy. J Hepatol (2012) 0.87
A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor. J Virol Methods (2005) 0.86
Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma. World J Gastroenterol (2012) 0.86
C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology (2010) 0.86
Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways. Autophagy (2015) 0.85
Identification of novel proteins from the venom of a cryptic snake Drysdalia coronoides by a combined transcriptomics and proteomics approach. J Proteome Res (2011) 0.85